KEMRI\CDC BUILDS NEW RESEARCH CENTER IN SIAYA DISTRICT.
Posted by African Press International on May 21, 2010
By ODHIAMBO DICKSON, KISUMU-KENYA.
THE Kenya Medical Research Institute and United States Center for Disease Control has embarked on constructing a new Clinical Research Center at Siaya District in Nyanza Province at a cost of about US Dollar 50 million.
The multi million project which is currently under construction at the compound of Siaya District Hospital will help in the ongoing research study of malaria and other diseases like HIV and Tuberculosis and will be linked with the Kisumu one for research Trials.
Speaking in Kisumu during an African Media and Malaria Research Network [AMMREN] workshop on Malaria, Kemri\CDC Head of Malaria Research Dr. Simon Kariuki said the need to have more space for research work has prompted the idea to have the new research center put in place.
Kariuki said the new facility will also serve as patients support center upon completion.
He said work on the new facility is expected to be completed by June this year.
Kariuki added that by August this year various research studies will have commenced to ease the work load at Siaya District Hospital.
Currently, Kemri\CDC is carrying out research study on malaria Vaccine Trial called RTS, S in the region.
Meanwhile, Kemri\CDC has rolled out a research study in Siaya District to evaluate different drug alternatives as intermittent preventive treatment for malaria in pregnancy.
The research trial which has kicked at Siaya District Hospital target to enroll 360 pregnant women with an aim of assessing whether mefloquine can prevent malaria in pregnant who are HIV positive.
Mefloquine is a registered drug and has been in the market for several years and is recommended for chemoprophylaxis for pregnant women travelers of all gestational ages by World Health Organization and CDC.
Dr. Kariuki said the study is being conducted under the auspices of Malaria in Pregnancy Preventive Alternative Drugs [MIPPAD].
He said four other Su-Saharan countries namely Tanzania , Mozambique , Gabon and Benin are also conducting the same study which is funded by European and Developing Countries Clinical Trials Partnership [EDCTP].
ENDS:
gioto samuel said
thats a good initiative, am sure it will be of great help to the research oriented students like me
Robinson kemei said
I hope medication for the fatal disease, malaria etc, will be realised soon
Robinson kemei said
What a great research expansion in Kenya with the help of KEMRI & CDC? Wish u the very best.
JOANES OSESO said
HAPPY TO FOLLOW YOUR PROCEEDINGS ONCE MORE. GOOD TIME
Loice Akelo. said
This is a worthy scientific approach, this project will really help the situation around the place and beyond. Good work CDC and KEMRI.
Joanes oseso said
This a gud idea n as a researcher i appreciate ths achievement. Proceed